These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6132660)
1. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system. Toffano G; Savoini G; Moroni F; Lombardi G; Calza L; Agnati LF Brain Res; 1983 Feb; 261(1):163-6. PubMed ID: 6132660 [No Abstract] [Full Text] [Related]
2. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat. Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756 [TBL] [Abstract][Full Text] [Related]
3. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion. Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339 [TBL] [Abstract][Full Text] [Related]
4. GM1 ganglioside does not stimulate reinnervation of the striatum by substantia nigra grafts. Freed WJ Brain Res Bull; 1985 Jan; 14(1):91-5. PubMed ID: 3986629 [TBL] [Abstract][Full Text] [Related]
5. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Agnati LF; Fuxe K; Calza L; Benfenati F; Cavicchioli L; Toffano G; Goldstein M Acta Physiol Scand; 1983 Dec; 119(4):347-63. PubMed ID: 6141701 [TBL] [Abstract][Full Text] [Related]
6. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons. Agnati LF; Fuxe K; Calza L; Goldstein M; Toffano G; Giardino L; Zoli M Acta Physiol Scand Suppl; 1984; 532():37-44. PubMed ID: 6594030 [TBL] [Abstract][Full Text] [Related]
8. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat. Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038 [No Abstract] [Full Text] [Related]
9. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra. Cumming P; Kamo H; McGeer EG; McGeer PL Neuropharmacology; 1987 Dec; 26(12):1795-7. PubMed ID: 2893988 [TBL] [Abstract][Full Text] [Related]
10. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Hadjiconstantinou M; Mariani AP; Neff NH Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752 [TBL] [Abstract][Full Text] [Related]
11. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839 [No Abstract] [Full Text] [Related]
12. Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside. Vaccari A; Stefanini E; de Montis G; Rossetti ZL Neuropharmacology; 1990 Dec; 29(12):1161-9. PubMed ID: 2149873 [TBL] [Abstract][Full Text] [Related]
13. tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway. Nishino H; Hashitani T; Isobe Y; Furuyama F; Sato H; Kumazaki M; Horikomi K; Awaya A Brain Res; 1990 Nov; 534(1-2):73-82. PubMed ID: 1981486 [TBL] [Abstract][Full Text] [Related]
14. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse. Itokazu Y; Fuchigami T; Morgan JC; Yu RK Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562 [TBL] [Abstract][Full Text] [Related]
16. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice. Schneider JS; Kean A; DiStefano L J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220 [TBL] [Abstract][Full Text] [Related]
17. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Hefti F; Melamed E; Wurtman RJ Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003 [TBL] [Abstract][Full Text] [Related]
18. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside. Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119 [TBL] [Abstract][Full Text] [Related]
19. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion. Baring MD; Walters JR; Eng N Brain Res; 1980 Jan; 181(1):214-8. PubMed ID: 7350957 [No Abstract] [Full Text] [Related]
20. Bilateral dopamine metabolism in the striatum after unilateral application of tetrodotoxine in the midbrain of the rat. Korf J; Postema F Brain Res; 1980 Apr; 187(1):251-5. PubMed ID: 7357473 [No Abstract] [Full Text] [Related] [Next] [New Search]